Reaction profile

The FDA adverse-event record for vomiting bile

715 FDA reports name vomiting bile, a high-volume reaction in the CVM extract (VeDDRA 2758). Plate stamps and neighbourhood peers follow.

#506 of 2,481
by report volume (all reactions)
715
reports citing this reaction
12.9%
death-coded share
Dog
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Vomiting bile has 715 reports now versus 683 in that prior snapshot: 32 more (4.7%).

Report change
+32
Death-coded reports
+3
Death-coded share
−0.2 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Vomiting bile changes

FDA AER · VeDDRA plate

Code 2758 VOL-MID

VOL-MID · DEATH-ELEV · UPPER-Q · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-MID 715 reports
  • DEATH-ELEV 12.9%
  • UPPER-Q #506/2481
  • PHOTO-FINISH Localised itching
  • SPECIES-DOG Dog · 609
  • DRUG-LEAD Afoxolaner · 67
  • DESK-WIDE 20 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Localised itching (±3 reports)

Upper-third report volume drives the scale stamps on this plate; death-coded share and co-report peers follow. Not a clinical diagnosis.

High-volume neighbourhood around Vomiting bile

Upper-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Ketonuria · near719Underfilling, Vials · near719Localised itching · near718Vomiting bile · this reaction715Elevated triglyceride · near711Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Vomiting bile

What the FDA AER plate says about Vomiting bile

Signature read: 715 reports place Vomiting bile in the upper third of FDA AER volume (#506 of 2,481). Report volume is upper-third scale: 715 named reports in the openFDA extract. 92 of 715 reports were death-coded (12.9% of named reports, not a population mortality rate). Nearest volume peer: Localised itching (±3 reports). Lead species Dog (609). Lead co-reported drug Afoxolaner (67).

Read these counts as reporting volume, not risk: per our methodology, Lead co-reported drug Afoxolaner appears in filings alongside this reaction; that is association, not causation. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 609
Cat 106

Breeds Most Affected

Domestic Shorthair 66
Retriever - Labrador 52
Crossbred Canine/dog 46
Retriever - Golden 33
Shih Tzu 28
Chihuahua 26
Dog (unknown) 24
Terrier - Yorkshire 22
Shepherd Dog - Australian 17
Maltese 15

Associated Drugs

Afoxolaner 67
Maropitant Citrate 63
Bedinvetmab 63
Pyrantel Pamoate;Sarolaner 61
Fluralaner 13.64% 12-Week Chew 47
Ivermectin + Pyrantel As Pamoate Salt 40
Milbemycin Oxime + Praziquantel 39
Carprofen 32
Moxidectin 30
Lotilaner 30
Gabapentin 24
Milbemycin Oxime + Spinosad 23
Oclacitinib Maleate 22
Unspecified 20
Trilostane 18
Grapiprant 17
Bexagliflozin 16
Pimobendan 15
Fluid Therapy 15
Praziquantel + Pyrantel Pamoate 14

Nationwide reactions with similar profiles

Two openFDA-derived peer sets for Vomiting bile, both floored at ≥50 reports so the neighborhoods stay in the advertised mass (the volume chart above is the unfloored photo-finish strip).

Similar report volume

Nearest other reactions by FDA report count (715 here).

Similar death-coded share

Nearest other reactions by death-coded share (12.9% here), distinct from the volume row.

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Vomiting bile (#506 of 2,481 by report volume); death-coded 12.9%. PlainBreed reaction plate · report volume stamp 715 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →